Rapid, Innovative Testing Products to Help Diagnose Health Issues for Women
BioMedomics is proud of its innovative solutions to aid in the diagnosis of diseases that affect women. We’re dedicated to developing advanced diagnostics products which help deliver better health outcomes for patients. We give special attention to underserved patient populations and diseases where current diagnostic methods are quite costly and impractical for many communities around the world.
BioMedomics Femi SCAN, the world’s first dual fluorescence staining agent to aid in the diagnosis of vaginal infections, makes diagnosis a reality for those who need it most. Clinicians can conduct the simple test in three easy steps and get results in less than 5 minutes. Femi SCAN is like three staining agents in one, and can help distinguish between bacterial, fungal, and parasitic microbes–critical information for the successful treatment of vaginal infections.
BioMedomics expertise in cell staining technologies and antibody development allows us to develop novel staining agents and diagnostic tests to assist clinicians in the diagnosis of conditions that affect womens health. From fluorescence to antibody-based stains, to lateral flow platforms, BioMedomics is constantly looking to find solutions that benefit women worldwide.
In the United States, about 30% of women between the ages of 14 and 49 are affected by bacterial vaginosis, one of several causes of vaginal infection. Each year, women in the USA make 10 million office visits for vaginal infections. While common, accurate diagnosis of vaginal infections is crucial. According to the American College of Obstetricians and Gynecologists clinical management guidelines, “Vaginitis has a broad differential diagnosis and successful treatment frequently rests on accurate diagnosis.” Three different pathogens are the most common cause of infectious vaginitis: bacteria, candida albicans (yeast infection), and trichomonas. Effective treatments are different for all three.